Edward M. Kaye
2016 - Sarepta Therapeutics
In 2016, Edward M. Kaye earned a total compensation of $3.4M as President and Chief Executive Officer at Sarepta Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $429,000 |
|---|---|
| Option Awards | $2,385,220 |
| Salary | $532,099 |
| Stock Awards | $64,492 |
| Other | $18,197 |
| Total | $3,429,008 |
Kaye received $2.4M in option awards, accounting for 70% of the total pay in 2016.
Kaye also received $429K in non-equity incentive plan, $532.1K in salary, $64.5K in stock awards and $18.2K in other compensation.
Rankings
In 2016, Edward M. Kaye's compensation ranked 2,710th out of 14,075 executives tracked by ExecPay. In other words, Kaye earned more than 80.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,710 out of 14,075 | 81st |
Division Manufacturing | 932 out of 5,489 | 83rd |
Major group Chemicals And Allied Products | 274 out of 1,895 | 86th |
Industry group Drugs | 200 out of 1,538 | 87th |
Industry Pharmaceutical Preparations | 152 out of 1,176 | 87th |
Source: SEC filing on April 27, 2017.
Kaye's colleagues
We found four more compensation records of executives who worked with Edward M. Kaye at Sarepta Therapeutics in 2016.
2016
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2016
David Howton
Sarepta Therapeutics
General Counsel
2016
Shamim Ruff
Sarepta Therapeutics
Senior Vice President, Regulatory Affairs and Quality
2016
Alexander Cumbo
Sarepta Therapeutics